Supplementary Figure 1 A B catalase p53 catalase MW(kDa) PIG3 MW(kDa)

Slides:



Advertisements
Similar presentations
25 A hMLH1 B Acetylated H3 Enrichment SW480 RKO Position from +1 BBII ++-- SW480 BIBI ++-- RKO C hMLH1 GAPDH Ab D Methyl-H3-K4 enrichment Position.
Advertisements

Jungwirth et al. Suppl. Fig. 1 A B. Jungwirth et al. Suppl. Fig. 2 HCT-116  -actin Bim EL Bak Bax - + KP46 A A C KP46 (µM) hours.
CD68 NE-SSE NE-NS Figure E1. Nrf2 42-kD  actin 32-kD HO kD Control si RNA si RNA Nrf2 Control si RNA si RNA Nrf2 Control si RNA si RNA Nrf2 Control.
Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE WI MCF10A HCT HCT116.
Supplementary Figure 1. DAXX S564A does not change Mdm2/p53 stability or p53 ‑ mediated gene expression. (A) U2OS cells stably transduced with pCDH-DAXX.
PatientVPA final dose (mg/kg/day) VPA final serum level (mM)(mg/L) Supplemental.
Supplementary Figure 1. Quantification of the amount of the H2O2 generated by glucose oxidase in culture medium. Comparison of the increase in DCF fluorescence.
Figure S UV- UV+ Relative expression levels of rhoB mRNA by qRT-PCR *
Cell Count DNA Content 0 hr24 hr48 hr 72 hr Empty Vector Strep Claspin (Induced) Strep Claspin (Uninduced) DNA content (Dapi) Strep A B C McGarry et al.
Figure S1 HA-FOXO3 wt C terminus ab HA-FOXO3 wt HA ab untransfected C terminus ab untransfected HA ab
Supplementary information Figure S1 Parental Mock ANXA1-V5 GAPDH MCF7-EV MCF7-V5 4 5 ANXA1 ANXA1-V5 Tubulin MCF7-parental MCF7-EV MCF7-V A B C ANXA1.
a GM DM1 DM3 DM5 DM7 b MHC MHC +DAPI GM DM4
Neuroprotective Effect of Didymin on Hydrogen Peroxide-Induced Injury in the Neuronal Membrane System Cells Tissues Organs 2014;199: DOI: /
Figure S2 apoptosis-PARP -WB
A B C D Rao et al., 2012; Supplementary Figure S1 p = 0.03 p = NS
* Supplementary Figure 1 A N.S B C D E basal Glycolytic reserve
A B Fig. 1C Fig. 2A (G007-LK) Tanaka et al. Supplementary Figure S1 -
Volume 34, Issue 6, Pages (June 2009)
Supplemental Figures Supplemental Figure 1.
Mitophagy is independent of PINK1 and Parkin.
Red: stable co-clustering Blue: no co-clustering
Volume 50, Issue 3, Pages (May 2013)
Inhibition of cytochrome P450 2E1 and activation of transcription factor Nrf2 are renoprotective in myoglobinuric acute kidney injury  Zhe Wang, Sudhir.
Volume 14, Issue 6, Pages (December 2008)
Supplementary Figure S1 Supplementary Figure S2
Supplementary Figure 1 Negative control IC50 110 mM (acetate)
Supplementary Figure 1 Non-migrating cells Migrating cells
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Volume 3, Issue 3, Pages (September 2002)
Supplementary Figure S1: FGFR4 silencing synergistically enhances the effects of chemotherapy in colon cancer cells. siFGFR4 FGFR4_6 FGFR4_2 Neg Con FGFR4.
Supplementary Figure 2. Effect of IL-32 and siRNA of IL-32 on melanoma, colon and prostate cancer cell growth and apoptosis as well as IL-32 expression.
Volume 73, Issue 5, Pages (March 2008)
relative to untreated vector
p53 Stabilization and Transactivation by a von Hippel-Lindau Protein
Redox Regulation by Pitx2 and Pitx3 Is Critical for Fetal Myogenesis
Volume 17, Issue 3, Pages (February 2005)
Simvastatin Protects Human Melanocytes from H2O2-Induced Oxidative Stress by Activating Nrf2  Yuqian Chang, Shuli Li, Weinan Guo, Yuqi Yang, Weigang Zhang,
Volume 67, Issue 5, Pages e5 (September 2017)
Relative protein levels
Supplemental Figure 1 a b c d.
Supplementary Fig. S1 * * * * * * * * * * WS (µg/ml) + H2O2 (500 µM)
Supplementary Figure S1
Volume 9, Issue 5, Pages (May 2002)
Volume 59, Issue 2, Pages (July 2015)
Supplementary Figure 1. A
Supplementary Figure 1 IP: IgG HA 3HA-E2F1: cIAP1: wt K
Supplementary Figures
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
Supplementary Figure S4
Volume 137, Issue 4, Pages (May 2009)
Volume 119, Issue 4, Pages (November 2004)
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Volume 21, Issue 11, Pages (November 2014)
Volume 115, Issue 2, Pages (October 2003)
Volume 10, Issue 2, Pages (January 2015)
Specific Killing of Rb Mutant Cancer Cells by Inactivating TSC2
Volume 25, Issue 5, Pages (March 2007)
Volume 4, Issue 5, Pages (May 2015)
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Supplementary Figure 1 A B C SW620 HT29 SW620
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 123, Issue 6, Pages (December 2005)
Pin1 Links the Activities of c-Abl and p300 in Regulating p73 Function
Dong Zhang, Kathrin Zaugg, Tak W. Mak, Stephen J. Elledge  Cell 
S. cerevisiae Bre1p confers resistance to apoptosis induced by H2O2.
The regulatory domain of HSF1 is involved in the pro-apoptotic response to TNF. (A) Upper panel, functional domains and potential DAPK phosphorylation.
TRAF6 enhances I/R-induced oxidative stress.
Polyamine concentration (nmol/mg protein)
SiRNA silencing of CDH3, CLDN1, KRT23, and MMP7 (A–D) in adenoma and CRC cell lines significantly reduces cell proliferation. siRNA silencing of CDH3,
Supplementary Fig. 1.
Presentation transcript:

Supplementary Figure 1 A B catalase p53 catalase MW(kDa) PIG3 MW(kDa) 72 55 43 34 26 95 130 170 PIG3 catalase MW(kDa) 72 55 43 34 1

Supplementary Figure 2 A B Vector PIG3 DCF fluorescence level Vector H1299 HCT116 p53-/- SW480 20 40 60 80 100 120 140 160  1.4    1.2 1.0 0.8 Catalase activity (U/ml) 0.6 0.4 0.2 0.0 SW480 H1299 HCT116 p53-/- PIG3 catalase -tubulin

Supplementary Figure 3 U2OS RKO HCT116 siRNA Control p53 Control p53 catalase p53R2 SESN1 SESN2 GPX1 ALDH4A1 SOD2 TIGAR Nrf-2 TP53INP1 GAPDH 3

Supplementary Figure 4 UV (10 J/m2) H2O2 (mM) HCT116 p53-/- HCT116 0 4 8 12 24 0 4 8 12 24 (hr) 0 0.05 0.1 1 2 0 0.05 0.1 1 2 p53 p53R2 catalase -tubulin UV (10 J/m2) H2O2 (mM) Saos-2 U2OS Saos-2 U2OS 0 4 8 12 24 0 4 8 12 24 (hr) 0 0.05 0.1 1 2 0 0.05 0.1 1 2 p53 p53R2 catalase -tubulin

Supplementary Figure 5 MW(kDa) 72 55 43 catalase p53R2 5

Supplementary Figure 6 A B ROS levels (%) 20 40 60 80 100 120 vector 20 40 60 80 100 120 vector wt R2 R4  n.s.  n.s. 250  200 150 Catalase activity (%) 100 50 vector wt R2 R4 6

Supplementary Figure 7 B A Control siRNA p53R2 siRNA 160 Control siRNA 140    120 n.s. 1.8 1.6 100 ROS levels (%) 1.4  80 n.s. 1.2 60 1.0 Catalase activity (U/ml) 0.8 40 0.6 20 0.4 0.2 U2OS RKO HCT116 0.0 U2OS RKO HCT116 p53R2 catalase -tubulin 7

Supplementary Figure 8 A B 2.5   n.s. n.s. n.s. 120 n.s. n.s.  Control vector Wild-type p53R2 Mutant p53R2 (V115L) Control vector Wild-type p53R2 Mutant p53R2 (V115L) 2.5   n.s. n.s. n.s. 120 n.s. n.s.    2.0 100  n.s. 1.5 80 Catalase activity (U/ml) 1.0 ROS levels (%) 60 40 0.5 20 0.0 U2OS RKO HCT116 p53R2 U2OS RKO HCT116 catalase -tubulin 8

Supplementary Figure 9 UT UV (10 J/m2) Sup P Sup P p53 PIG3 p53R2 Catalase β-actin PMP70

Supplementary Figure 10 catalase merge DAPI p53 UT p53R2 p53 UV (10 J/m2) p53R2

Supplementary Figure 11 A B U2OS (vector) U2OS (catalase) 200   180 35 160 30 140  25 120 ROS levels (%) Apoptosis (%) 100 20 80 15  60 10 40 20 5 8 24 h 24 48 h UV (40 J/m2) UV (40 J/m2)

Supplementary Figure 12 H1299 (vector) H1299 (catalase) 180  160 140 120 ROS levels (%) 100 80 60 40 20 Ad p53 48 h 12

Supplementary Figure 13 Untreated control UV (20 J/m2) 200  180 160 140 120 ROS levels (%) 100 80 60 40 20 Vector PIG3 HCT116 p53-/-